Skip to Content

Join the 'Pancrelipase' group to help and get support from people like you.

Pancrelipase News

Special Diet May Be Boon for Kids With Crohn's, Colitis

Posted 10 Jan 2017 by Drugs.com

MONDAY, Jan. 9, 2017 – Children with Crohn's disease and ulcerative colitis may be able to achieve relief without medications by eating a special diet, a small study suggests. The diet includes non-processed foods, such as fruits, vegetables, meats and nuts. Over 12 weeks, the diet appeared to ease all signs of these inflammatory bowel diseases in eight of the 10 affected children, researchers ...

Digestive Care, Inc. Announces FDA Approval of Pertzye (pancrelipase) Delayed-Release Capsules

Posted 18 May 2012 by Drugs.com

BETHLEHEM, Pa., May 18, 2012 /PRNewswire/ – Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for Pertzye, indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions. Pertzye is a unique pancreatic enzyme product containing ...

Aptalis Pharma Announces FDA Approval of Viokace (Pancrelipase) Tablets

Posted 1 Mar 2012 by Drugs.com

BRIDGEWATER, NJ--(Marketwire - March 1, 2012) - Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, announced that the U.S. Food and Drug Administration (FDA) has approved Viokace (pancrelipase) tablets. Viokace (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or ...

Aptalis Pharma Announces FDA Approval of Ultresa (Pancrelipase) Delayed Release Capsules

Posted 1 Mar 2012 by Drugs.com

BRIDGEWATER, NJ--(Marketwire - March 1, 2012) - Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, announced that the U.S. Food and Drug Administration (FDA) has approved Ultresa (pancrelipase) Delayed Release Capsules. Ultresa (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis ...

Ultresa and Viokace Pancreatic-Enzyme Products Approved

Posted 1 Mar 2012 by Drugs.com

THURSDAY, March 1 – Two drugs that supplement the digestion-aiding actions of pancreatic enzymes have been approved by the U.S. Food and Drug Administration, the agency said Thursday in a news release. Ultresa (pancrelipase) was approved for adults and children with cystic fibrosis and other disorders that affect food digestion because the pancreas does not produce enough enzymes, the FDA said. ...

FDA Approves Pancreatic Enzyme Product, Pancreaze

Posted 13 Apr 2010 by Drugs.com

SILVER SPRING, Md., April 12 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Pancreaze Delayed Release Capsules, a pancreatic enzyme product (PEP). It is the third such product to receive FDA approval. Pancreatic enzyme products improve food digestion in patients whose bodies do not produce enough pancreatic enzymes. This includes people who have conditions such as ...

Eurand Granted FDA Approval for Zenpep

Posted 2 Dec 2009 by Drugs.com

PHILADELPHIA, PA, Aug 28, 2009 – Eurand N.V., a specialty pharmaceutical company, today announced U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for Zenpep (pancrelipase) Delayed-Release Capsules for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions. Zenpep is the only FDA-approved pancreatic ...

Ask a Question

Further Information

Related Condition Support Groups

Chronic Pancreatitis, Pancreatic Exocrine Dysfunction, Cystic Fibrosis

Related Drug Support Groups

Creon, Zenpep, Pancrease, Creon 10, Viokase, Creon 20, Pancreaze, Ultrase, Ultrase MT 20, view more... Pancrease MT 20, Pancrease MT 10, Pancrease MT 4, Panokase, Viokace, Creon 5, Ultrase MT 12, Viokase 16, Viokase 8, Panase, Pancrease MT 16, Pancreatil-UL 12, Pancrecarb MS-16, Pancrecarb MS-4, Pancrecarb MS-8, Pancron D / R, Lapase, Pangestyme CN 10, Pangestyme CN 20, Pangestyme EC, Pangestyme MT 16, Pancrease MT, Arco-Lase, Pangestyme UL 18, Pangestyme UL 20, Cotazym, Cotazym-S, Panocaps, Panocaps MT 16, Panokase 16, Protilase, Protilase MT-16, Ilozyme, Ultresa, Lipram UL, Encron-10, Ultrase MT 18, Lipram, Lipram-CR, Lipram-CR10, Lipram-CR20, Lipram-CR5, Lipram-PN10, Lipram-PN16, Lipram-PN20, Lipram-UL 12, Lipram-UL 18, Lipram-UL 20, Plaretase, Zymase, Pancrecarb MS, Ku-Zyme, Pertzye, Ku-Zyme HP, Dygase, Kutrase, Palcaps 10, Vio-Moore

Pancrelipase Patient Information at Drugs.com